Comparison of risedronate versus placebo in preventing anastrozole-induced bone loss in women at high risk of developing breast cancer with osteopenia. (2019)

First Author: Sestak I
Attributed to:  Centre for Integrated research into Musculoskeletal Ageing (CIMA) Renewal funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.bone.2019.04.016

PubMed Identifier: 31028957

Publication URI: http://europepmc.org/abstract/MED/31028957

Type: Journal Article/Review

Volume: 124

Parent Publication: Bone

ISSN: 1873-2763